🔗 Visit the ClinicalTrials.gov page for NCT01068782
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting the HGF/Met signaling pathway in cancer therapy. | Expert Opin Ther Targets | 2012 | 1.45 |
| 2 | Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. | J Clin Oncol | 2015 | 1.06 |
| 3 | The treatment landscape in thyroid cancer: a focus on cabozantinib. | Cancer Manag Res | 2015 | 0.79 |